Management of Early-Stage Endometrial Cancer

Seminars in Oncology

Volumn 36, Issue 2, 2009, Pages 137-144

  Lu, Karen H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUORODEOXYGLUCOSE; GESTAGEN; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; PACLITAXEL; PLATINUM; PROGESTERONE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ENDOMETRIUM CANCER; HUMAN; HYSTERECTOMY; LYMPHADENECTOMY; MEDICAL PRACTICE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SALVAGE THERAPY; TUMOR RECURRENCE;

CHEMOTHERAPY, ADJUVANT; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 62949186594     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2008.12.005     Document Type: Article

References (67)

1. Cancer facts and figures 2008. http://www.cancer.org/docroot/PRO/content/PRO_1_1_Cancer_Statistics_2008_Presentation.asp
2. In: Ries Y.J., Gloeckler L.A., LAG, Keel G.E., Eisner M.P., Lin Y.D., and Horner M.-J. (Eds). SEER survival monograph: cancer survival among adults: U.S. SEER program, 1988-2001, patient and tumor characteristics (2007) Bethesda, MD
3. Keys H.M., Roberts J.A., Brunetto V.L., Zaino R.J., Spirtos N.M., Bloss J.D., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92 (2004) 744-751
4. Creutzberg C.L., van Putten W.L., Koper P.C., Lybeert M.L., Jobsen J.J., Wárlám-Rodenhuis C.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355 (2000) 1404-1411
5. Paul F., Dijkhuizen H.L.J., Mol B.W.J., Brölmann H.A.M., and Heintz A.P.M. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer 89 (2000) 1765-1772
6. Benedet D.L., Bender H., Jones H., Ngan S., Pecorelli S., and FIGO Committee on Gynecologic Oncology. Staging classifications and clinical practice guidelines for gynaecologic cancers. Int J Gynecol Obstet 70 (2000) 209-262
7. Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., and Heller P.B. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer 60 Suppl (1987) 2035-2041
8. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol 106 (2005) 413-425
9. Kwon J.S., Carey M.S., Cook E.F., Qiu F., and Paszat L. Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study. Int J Gynecol Cancer 17 (2007) 433-440
10. Daniel A.G., and Peters III W.A. Accuracy of office and operating room curettage in the grading of endometrial carcinoma. Obstet Gynecol 71 (1988) 612-614
11. Frumovitz M., Singh D.K., Meyer L., Smith D.H., Wertheim I., Resnik E., and Bodurka D.C. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol 95 (2004) 463-468
12. Larson D.M., Johnson K.K., Broste S.K., Krawisz B.R., and Kresl J.J. Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol 86 (1995) 38-42
13. Franchi M., Ghezzi F., Melpignano M., Cherchi P.L., Scarabelli C., Apolloni C., et al. Clinical value of intraoperative gross examination in endometrial cancer. Gynecol Oncol 76 (2000) 357-361
14. Larson D.M., Connor G.P., Broste S.K., Krawisz B.R., and Johnson K.K. Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 88 (1996) 394-398
15. Doering D.L., Barnhill D.R., Weiser E.B., Burke T.W., Woodward J.E., and Park R.C. Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma. Obstet Gynecol 74 (1989) 930-933
16. Chuang L., Burke T.W., Tornos C., Marino B.D., Mitchell M.F., Tortolero-Luna G., et al. Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol 58 (1995) 189-193
17. Arango H.A., Hoffman M.S., Roberts W.S., DeCesare S.L., Fiorica J.V., and Drake J. Accuracy of lymph node palpation to determine need for lymphadenectomy in gynecologic malignancies. Obstet Gynecol 95 (2000) 553-556
18. McMeekin D.S., Lashbrook D., Gold M., Johnson G., Walker J.L., and Mannel R. Analysis of FIGO stage IIIc endometrial cancer patients. Gynecol Oncol 81 (2001) 273-278
19. Mariani A., Dowdy S.C., Cliby W.A., Gostout B.S., Jones M.B., Wilson T.O., et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109 (2008) 11-18
20. Orr Jr. J.W., Holimon J.L., and Orr P.F. Stage I corpus cancer: is teletherapy necessary?. Am J Obstet Gynecol 176 (1997) 777-788
21. Frumovitz M., Bodurka D.C., Broaddus R.R., Coleman R.L., Sood A.K., Gershenson D.M., et al. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol 104 (2007) 100-103
22. Niikura H., Okamura C., Utsunomiya H., Yoshinaga K., Akahira J., Ito K., et al. Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol 92 (2004) 669-674
23. Burke T.W., Levenback C., Tornos C., Morris M., Wharton J.T., and Gershenson D.M. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 62 (1996) 169-173
24. 99mTc-labelled albumin nanocolloid in endometrial cancer. Eur J Nucl Med Mol Imaging 32 (2005) 569-574
25. Mariani A., Webb M.J., Keeney G.L., Haddock M.G., Calori G., and Podratz K.C. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?. Am J Obstet Gynecol 182 (2000) 1506-1519
26. Mariani A., Dowdy S.C., Keeney G.L., Haddock M.G., Lesnick T.G., and Podratz K.C. Predictors of vaginal relapse in stage I endometrial cancer. Gynecol Oncol 97 (2005) 820-827
27. Orr J.W. Surgical staging of endometrial cancer: does the patient benefit?. Gynecol Oncol 71 (1998) 335-339
28. Orr Jr. J.W., and Taylor Jr. P.T. Surgical management of endometrial cancer: how much is enough?. Gynecol Oncol 109 (2008) 1-3
29. Creutzberg C.L. Lymphadenectomy in apparent early-stage endometrial carcinoma: do numbers count?. J Clin Oncol 23 (2005) 3653-3655
30. Aalders J.G., and Thomas G. Endometrial cancer-revisiting the importance of pelvic and para aortic lymph nodes. Gynecol Oncol 104 (2007) 222-231
31. Kwon J.S., Carey M.S., Goldie S.J., and Kim J.J. Cost-effectiveness analysis of treatment strategies for stage I and II endometrial cancer. J Obstet Gynaecol Cancer 29 (2007) 131-139
32. Gemignani M.L., Curtin J.P., Zelmanovich J., Patel D.A., Venkatraman E., and Barakat R.R. Laparoscopic-assisted vaginal hysterectomy for endometrial cancer: clinical outcomes and hospital charges. Gynecol Oncol 73 (1999) 5-11
33. Eltabbakh G.H., Shamonki M.I., Moody J.M., and Garafano L.L. Laparoscopy as the primary modality for the treatment of women with endometrial carcinoma. Cancer 91 (2001) 378-387
34. Malur S., Possover M., Michels W., and Schneider A. Laparoscopic-assisted vaginal versus abdominal surgery in patients with endometrial cancer-a prospective randomized trial. Gynecol Oncol 80 (2001) 239-244
35. Kalogiannidis I., Lambrechts S., Amant F., Neven P., Van Gorp T., and Vergote I. Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome. Am J Obstet Gynecol 196 (2007) 248 e1-8
36. Ghezzi F., Cromi A., Bergamini V., Uccella S., Beretta P., Franchi M., et al. Laparoscopic-assisted vaginal hysterectomy versus total laparoscopic hysterectomy for the management of endometrial cancer: a randomized clinical trial. J Minim Invasive Gynecol 13 (2006) 114-120
37. Frigerio L., Gallo A., Ghezzi F., Trezzi G., Lussana M., and Franchi M. Laparoscopic-assisted vaginal hysterectomy versus abdominal hysterectomy in endometrial cancer. Int J Gynaecol Obstet 93 (2006) 209-213
38. Walker J., Manel R., Piedmonte M., Schlaerth J., Spirtos N., and Spiegel G. Phase III trial of laparoscopy versus laparotomy for surgical resection and comprehensive surgical staging of uterine cancer: a Gynecologic Oncology Group study funded by the National Cancer Institute. [abstract 21]. Gynecol Oncol 101 Suppl 1 (2006) 10
39. Aalders J., Abeler V., Kolstad P., and Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 56 (1980) 419-427
40. Lee C.M., Szabo A., Shrieve D.C., Macdonald O.K., and Gaffney D.K. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA 295 (2006) 389-397
41. Creutzberg C.L., van Putten W.L., Wárlám-Rodenhuis C.C., van den Bergh A.C., de Winter K.A., Koper P.C., et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol 22 (2004) 1234-1241
42. Greven K., Winter K., Underhill K., Fontenesci J., Cooper J., and Burke T. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol 103 (2006) 155-159
43. Hogberg T., Rosenberg P., Kristensen G., de Oliveira C.F., de Pont Christensen R., Sorbe B., et al. A randomized phase-III study on adjuvant treatment with radiation (RT) +/- chemotherapy (CT) in early stage high-risk endometrial cancer (NSGO-EC-9501/EORTC 55991. [abstract 5503]. J Clin Oncol 25 (2007) S18
44. Nout R.A., Putter H., Jurgenliemk-Schulz I.M., Jobsen J.J., Lutgens L.C., van der Steen-Banasik E.M., Mens J.W., et al. Vaginal bracytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: Results of the randomized PORTEC-2 trial. [abstract LBA5503]. J Clin Oncol 26 Suppl (2008)
45. Hamilton C.A., Cheung M.K., Osann K., Chen L., Teng N.N., Longacre T.A., et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer 94 (2006) 642-646
46. Cirisano Jr. F.D., Robboy S.J., Dodge R.K., Bentley R.C., Krigman H.R., Synan I.S., et al. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma. Gynecol Oncol 74 (1999) 385-394
47. Creasman W.T., Kohler M.F., Odicino F., Maisonneuve P., and Boyle P. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol 95 (2004) 593-596
48. Risinger J.I., Maxwell G.L., Chandramouli G.V.R., Jazaeri A., Aprelikova O., Patterson T., et al. Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer. Cancer Res 63 (2003) 6-11
49. Kosary C.L. Cancer of the corpus uteri. In: Ries Y.J., Gloeckler L.A., Keel G.E., Eisner M.P., Lin Y.D., and Horner M.-J. (Eds). SEER survival monograph: cancer survival among adults: U.S. SEER Program, 1988-2001, patient and tumor characteristics (2007), National Cancer Institute, Bethesda, MD SEER Program
50. Soliman P.T., Oh J.C., Schmeler K.M., Sun C.C., Slomovitz B.M., Gershenson D.M., et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 105 (2005) 575-580
51. Bokhman J.V., Chepick O.F., Volkova A.T., and Vishnevsky A.S. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy?. Gynecol Oncol 20 (1985) 139-155
52. Kim Y.B., Holschneider C.H., Ghosh K., Nieberg R.K., and Montz F.J. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer 79 (1997) 320-327
53. Randall T.C., and Kurman R.J. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 90 (1997) 434-440
54. Wang C.B., Wang C.J., Huang H.J., Hsueh S., Chou H., Soong Y.K., et al. Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer 94 (2002) 2192-2198
55. Gotlieb W.H., Beiner M.E., Shalmon B., Korach Y., Segal Y., Zmira N., et al. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstet Gynecol 102 (2003) 718-725
56. Yamazawa K., Seki K., Matsui H., Kihara M., and Sekiya S. Prognostic factors in young women with endometrial carcinoma: a report of 20 cases and review of literature. Int J Gynecol Cancer 10 (2000) 212-222
57. Tran B.N., Connell P.P., Waggoner S., Rotmensch J., and Mundt A.J. Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am J Clin Oncol 23 (2000) 476-480
58. Evans-Metcalf E.R., Brooks S.E., Reale F.R., and Baker S.P. Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 91 (1998) 349-354
59. Ramirez P.T., Frumovitz M., Bodurka D.C., Sun C.C., and Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol 95 (2004) 133-138
60. Frei K.A., Kinkel K., Bonél H.M., Lu Y., Zaloudek C., and Hricak H. Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging-a meta-analysis and Bayesian analysis. Radiology 216 (2000) 444-449
61. Manfredi R., Mirk P., Maresca G., Margariti P.A., Testa A., Zannoni G.F., et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231 (2004) 372-378
62. Kinkel K., Kaji Y., Yu K.K., Segal M.R., Lu Y., Powell C.B., et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 212 (1999) 711-718
63. Mitchard J., and Hirschowitz L. Concordance of FIGO grade of endometrial adenocarcinomas in biopsy and hysterectomy specimens. Histopathology 42 (2003) 372-378
64. Eltabbakh G.H., Shamonki J., and Mount S.L. Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors. Gynecol Oncol 99 (2005) 309-312
65. Walsh C., Holschneider C., Hoang Y., Tieu K., Karlan B., and Cass I. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol 106 (2005) 693-699
66. Montz F.J., Bristow R.E., Bovicelli A., Tomacruz R., and Kurman R.J. Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol 186 (2002) 651-657
67. Dhar K.K., NeedhiRajan T., Koslowski M., and Woolas R.P. Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer?. Report of four cases and review of the literature. Gynecol Oncol 97 (2005) 924-927